POST-DOCTORAL POSITIONS IN DRUG ABUSE PHARMACOLOGY AND TREATMENT AT THE UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES
We are currently seeking Post-Doctoral Fellows with strong technical skills in preclinical models of drug abuse, and broader interest in the science of drug addiction, for positions within two NIH/NIDA R01 projects "Antibody Gene Therapy for Methamphetamine Abuse," (Eric Peterson PI) and "Pharmacology and Therapy for MDPV and alpha-PVP Like Drugs of Abuse" (Michael Owens, PI) within the Department of Pharmacology and Toxicology, and our NIH/NIDA T32 "Translational Training in Addiction" (Clint Kilts, PI) at the University of Arkansas for Medical Sciences in Little Rock. The selected candidates will become members of our interdisciplinary collaborating laboratories with ongoing, funded projects related to development of novel pharmacotherapeutics for psychostimulant addiction and toxicities. The T32 fellowship position is funded for two years, while the R01-supported positions could be funded for up to 3 years.
Our laboratories within the Department of Pharmacology and Toxicology are especially focused on (1) using behavioral pharmacology assays to understand the abuse-related effects of drugs (i.e., intravenous self-administration, drug discrimination) as well as their persistent effects on physiology and behavior (i.e., biotelemetry of locomotor activity, thermoregulation and cardiovascular effects, as well as assays relevant to psychosis, learning and memory), (2) designing novel antibody-based medications against psychostimulants, which slow entry of these drugs into the brain by binding them in the blood. A synthesis of these two areas of research allows us to test the therapeutic potential of these novel pharmacotherapies using a range of in vitro and in vivo models, and provides a fertile interdisciplinary training environment for fellows. Our drug abuse research group is part of an extensive network of addiction science efforts across several research Centers and Colleges at UAMS, including analytical chemistry and product surveillance at the Arkansas Department of Health, clinical scientists at the Psychiatric Research Institute and the Arkansas Children's Hospital, community-based research programs through the Division of Health Services Research, and our own pharmacology laboratories within the College of Medicine. Successful candidates will have strong communication skills and clear technical expertise, with a focus on either in vitro (e.g., expression analysis, Western blots, and receptor binding assays) or in vivo (e.g., operant behavior, locomotor activity) models. Demonstrated ability to apply more advanced tools (e.g., pharmacokinetic modeling, HPLC separation and detection in biological samples), and the ability to integrate in vivo and in vitro measures will be an advantage. The ability to publish research findings is important for these training positions. Candidates will have completed an MD or Ph.D. or equivalent degree in a relevant discipline (e.g., biomedical engineering, pharmacology, neuroscience, biological psychology, etc.). The University of Arkansas for Medical Sciences is an Equal Opportunity / Affirmative Action Employer. Minorities and women are strongly encouraged to apply. US Citizenship or Permanent Resident status (green card) is required. Applications will be considered until the position is filled. Please e-mail an up-to-date CV, the names of 3 references, and a one-page letter of interest describing your potential fit for the position to Associate Professor of Pharmacology and Toxicology Dr. William Fantegrossi (WEFantegrossi@uams.edu).
For more information contact:
William Fantegrossi, Ph.D.
William W. Stoops, Ph.D.
University of Kentucky College of Medicine
Department of Behavioral Science
Department of Psychiatry
Center on Drug and Alcohol Research
University of Kentucky College of Arts and Sciences
Department of Psychology
phone: (859) 257-5383
facsimile: (859) 257-7684
STATEMENT OF CONFIDENTIALITY
The contents of this e-mail message and any attachments are
confidential and are intended solely for the addressee. The information
may also be legally privileged. This transmission is sent in trust, for
the sole purpose of delivery to the intended recipient. If you have
received this transmission in error, any use, reproduction or
dissemination of this transmission is strictly prohibited. If you are
not the intended recipient, please immediately notify the sender by
reply e-mail or at (859) 257-5383 and delete this message and its
attachments, if any.